Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Syros Pharmaceuticals Inc shares valued at $7,949 were sold by Stephens Kristin on Nov 18 ’24. At $0.22 per share, Stephens Kristin sold 36,133 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Roth David sold 12,099 shares, netting a total of over 2,382 in proceeds. Following the sale of shares at $0.20 each, the insider now holds 0 shares.
Before that, Quirk Gerald E had sold 46,657 shares from its account. In a trade valued at $10,321, the Chief Legal & Compliance Offic traded Syros Pharmaceuticals Inc shares for $0.22 each. Upon closing the transaction, the insider’s holdings decreased to 46,657 shares, worth approximately $0.0.
As published in a research note from H.C. Wainwright on November 04, 2020, Syros Pharmaceuticals Inc [SYRS] has been rated up from a Neutral to a Buy and the price target has been revised to $15 from $11. Analysts at Alliance Global Partners started covering the stock with ‘”a Buy”‘ outlook in a report released in late September. As of January 17, 2020, Wedbush has decreased its “an Outperform” rating to a “Neutral” for SYRS.
Analyzing SYRS Stock Performance
During the last five days, there has been a drop of approximately -19.22%. Over the course of the year, Syros Pharmaceuticals Inc shares have dropped approximately -96.28%. Shares of the company reached a 52-week high of $8.1700 on 01/02/24 and a 52-week low of $0.1830 on 11/18/24. A 50-day SMA is recorded $1.9141, while a 200-day SMA reached $4.3799. Nevertheless, trading volume fell to 16.05 million shares from 365.79 million shares the previous day.
Support And Resistance Levels for Syros Pharmaceuticals Inc (SYRS)
According to the 24-hour chart, there is a support level at 0.2593, which, if violated, would cause prices to drop to 0.2285. In the upper region, resistance lies at 0.3106. The next price resistance is at 0.3311. RSI (Relative Strength Index) is 28.95 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.3494, which suggests the price will decrease in the coming days. Percent R is at 96.67%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
